Angiostatic steroid. Prepn: J. Fried, E. F. Sabo, J. Am. Chem. Soc. 75, 2273 (1953); R. P. Graber et al., ibid. 4722; J. Fried, E. F. Sabo, ibid. 79, 1130 (1957). Angiostatic activity in vitro: L. G. McNatt et al., J. Ocul. Pharmacol. Ther. 15, 413 (1999); in vivo: D. BenEzra et al., Invest. Ophthalmol. Visual Sci. 38, 1954 (1997). Clinical study in age-related macular degeneration: J. S. Slakter et al., Ophthalmology 110, 2372 (2003). Review of pharmacology: A. F. Clark, Expert Opin. Invest. Drugs 6, 1867-1877 (1997); and clinical experience: S. A. Vinores, IDrugs 8, 327-334 (2005).
In treatment of macular degeneration.
Macular Degeneration Treatment